Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-26.36	42.20	57.30
Graham Fair Price	38.24	161595.05	116896.62
PEG	-85.64	0.04	-0.25
Price/Book	0.94	0.31	0.31
Price/Cash Flow	17.32	-1.81	-2.19
Prices/Earnings	-39.66	2.87	4.75
Price/Sales	17.09	4.46	3.81
Price/FCF	17.32	-1.81	-2.19
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-0.10	0.96	0.96
Operating Margin	50.67	1.07	0.71
ROA	80.13	< 0.005	< 0.005
ROE	0.02	0.03	67.27
ROIC	< 0.005	0.02	100.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.03	6.02	-99.47
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.46	0.35	-75.86
EPS QOQ	-0.19	0.79	320.22
FCF QOQ	-10.65	-0.27	97.46
Revenue QOQ	0.38	-0.10	-72.94
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	905.42	721.26	-20.34
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.77	0.75	-1.73
Quick Ratio	0.48	0.34	-28.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	193722.50	207062.13	6.89
Cash	136507.37	93601.58	-31.43
Capex	-332.87	-308.47	7.33
Free Cash Flow	-27192.95	-35483.15	-30.49
Revenue	15658.14	14426.78	-7.86
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	52.09	38.11	-26.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating